🟢 Tscan Therapeutics is trading 5.86% up in after-hours trading after rebounding from heavy selling tied to reorganization

Tscan Therapeutics is trading 5.86% up at $0.36 in after-hours trading after rebounding from heavy recent selling tied to its reorganization.

• It closed at $0.34 on September 8, 2026.
• The September 2 reorganization prioritized in-vivo solid-tumor programs, paused further ALLOHA-2 enrollment, reduced staffing, and cut costs.
• Analyst downgrades followed, including Wedbush’s move to Neutral.